Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study

Treatment and Survival Outcome for Molecular Breast Cancer Subtypes in Black Women

(2009) Chukwuemeka U. Ihemelandu et al.   ANNALS OF SURGERY

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

(2009) E. A. Rakha et al.   CLINICAL CANCER RESEARCH

Bright-field In Situ Hybridization for HER2 Gene Amplification in Breast Cancer Using Tissue Microarrays

(2009) Glenn D. Francis et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis

(2009) Ping Tang et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Evaluation of automated silver-enhancedin situhybridization (SISH) for detection ofHER2gene amplification in breast carcinoma excision and core biopsy specimens

(2009) S Shousha et al.   HISTOPATHOLOGY

Characteristics and prognosis for molecular breast cancer subtypes in Chinese women

(2009) Jing Zhao et al.   JOURNAL OF SURGICAL ONCOLOGY

Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland

(2008) A. Spitale et al.   ANNALS OF ONCOLOGY

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

(2008) Mary Jo Lund et al.   BREAST CANCER RESEARCH AND TREATMENT

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinomain situof the breast

(2008) F Wärnberg et al.   HISTOPATHOLOGY

Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?

(2008) Ping Tang et al.   HUMAN PATHOLOGY